From MYOD1 to iPS cells

Affiliations

¹ Howard Hughes Medical Institute at Massachusetts General Hospital, Cancer Center and Center for Regenerative Medicine, Harvard Stem Cell Institute, and Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School, Boston, Massachusetts, USA. khochedlinger@helix.mgh.harvard.edu

Comment

Konrad Hochedlinger. Nat Rev Mol Cell Biol. 2010 Dec.

. 2010 Dec;11(12):817.

doi: 10.1038/nrm3018.

¹ Howard Hughes Medical Institute at Massachusetts General Hospital, Cancer Center and Center for Regenerative Medicine, Harvard Stem Cell Institute, and Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School, Boston, Massachusetts, USA. khochedlinger@helix.mgh.harvard.edu

No abstract available

Comment on

Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.
Taylor SM, Jones PA. Taylor SM, et al. Cell. 1979 Aug;17(4):771-9. doi: 10.1016/0092-8674(79)90317-9. Cell. 1979. PMID: 90553
Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts.
Lassar AB, Paterson BM, Weintraub H. Lassar AB, et al. Cell. 1986 Dec 5;47(5):649-56. doi: 10.1016/0092-8674(86)90507-6. Cell. 1986. PMID: 2430720
Expression of a single transfected cDNA converts fibroblasts to myoblasts.
Davis RL, Weintraub H, Lassar AB. Davis RL, et al. Cell. 1987 Dec 24;51(6):987-1000. doi: 10.1016/0092-8674(87)90585-x. Cell. 1987. PMID: 3690668